Peer Review History
| Original SubmissionDecember 15, 2020 |
|---|
|
PONE-D-20-39104 Prevalence of unculturable bacteria in the dentoalveolar abscess and related periapical lesions: A systematic review and meta-analysis PLOS ONE Dear Dr. Hamoudi, First, please accept our apologies for having waited so long for our decision on your submitted draft. Unfortunately, the original Editor was, and I have stepped in as the Academic Editor some few hours ago.Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.Having intensively reviewed your draft, several minor and major shortcomings have been identified by our external experts. Therefore, I have double checked your submission, to come to a more balanced decision. No doubt, the concerns indicated by our reviewers cannot be ignored. Thus, after deliberate consideration, the Editorial Board feels that your manuscript's quality should be increased prior to re-entering into a further review process, to forward an improved draft of your work to further external reviewers. All in all, the indicated shortcomings are considered reasonable with regard to both PLOS ONE's quality standards and our readership's expectations, and another round of revisions would seem mandatory. Please note that your re-submitted draft will again be forwarded to re-review.Therefore, we invite you to submit a thoroughly revised version of the manuscript that addresses EACH AND EVERY point raised during this review process. Please note that another non-convincing revision (not considered acceptable with regard to language, content, reviewers' constructive criticism, generalizable conclusions, and/or Authors' Guidelines) will lead to outright reject.Please submit your revised manuscript by Jul 01 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.Please include the following items when submitting your revised manuscript:- A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.- A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.- An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.Please submit your revised manuscript by Jul 05 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Andrej M Kielbassa Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include captions for ALL your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Partly Reviewer #5: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes Reviewer #3: Yes Reviewer #4: Yes Reviewer #5: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The study brings new information and its objective can be relevant. Although a lot of work has been done, this submission has concerns that are listed below: - Abstract: Line 22: “To assess the prevalence of unculturable bacteria in dentoalveolar abscess (DAA) and related periapical lesions.” What lesions? Line 26: Which month of 2020 was the search conducted? Methods: Which were the eligibility criteria? What type of studies was included? Were the risk of bias, meta-regression and publication bias assessed? How was the effect measured? What type of statistical analysis was performed? I suggest rewriting the results as follows: Approximately 13% (%95 CI: 7-23%) of the cumulative... On the results the author affirms “Country moderator significantly ( P -value = 0.05) affects the diversity summary proportion.”, but it was not mentioned on the methods. The conclusion is not in accordance with the objective of the study. I suggest rewriting the conclusion as follows: “The moderate, yet significant prevalence of unculturable bacteria in such lesions, SUGGESTS that they are likely to play,...” - Introduction Authors should provide more information about the importance of the knowledge on the prevalence of unculturable bacteria in the dentoalveolar abscess and related periapical lesions to improve the background and also enrich the discussion of the results. Line 51: “initiate the periapical pathology that eventually results in a DAA and its sequelae” What sequelae? I think the authors should discuss DAA and the related periapical lesions. Why did the author choose the Nair’s classification? Line 60: “Periapical granuloma is a misnomer as it does not contain granulomatous tissue”. I suggest that the authors include new and current references to confirm this statement. Line 62: Authors could include referenced to this statement. Authors could use a single terminology to DAA, apical abscess and periapical abscess throughout the study. I think it is necessary to clarify why it would be important to compile data on this topic. According to PRISMA checklist “Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).” Therefore, authors could include the terms “DAA and related periapical lesions” on the objective of the study (line 90). If possible, specify which “related periapical lesions”. - Materials and Methods The study could be rewritten and qualified according to the PRISMA Preferred reporting items for systematic reviews and meta‐analyses, available at https://onlinelibrary.wiley.com/doi/full/10.1111/iej.13118 Lines 96 and 98 – Fig 1 should be moved to the results section. Line 105 – Authors could review the search period. In the abstract, the authors affirm that “databases were systematically searched from 1990 to 2020”. In the methodology they affirm that “the search was limited to human studies published 105 over a decade, from 1990/01/01 to 2019/12/31”. The reference number 40 corresponds to a study published in April 2020. Have reviewers been previously calibrated to ensure inter‐rater reliability for the search and for the risk of bias assessment? The exclusion criteria must be selected previously to conducting the study, and not according to the results. This would characterize a selection bias. The criteria presentation leaves doubt whether the criteria were previously established or not. In addition, the number of articles excluded according to each criterion must be presented in the results, not in the methods. Line 123, 129, 131 and 132: Fig 1, Table 1, 2, 3 and S2 should be moved to the results section. S2 Table and Table 3 are redundant. Line 163: in this section, please include the customized checklist used to Risk of bias assessment (S3 Table). Line 169: “Finally, all studies with a minimum score of 6/8 for 170 were included in the review.” Was it a criteria of inclusion or the result of the Risk of bias assessment? Line 195: Please specify what is PCA in the first time you use this term on the text. Line 201: Authors do not mention the duplicates removal. In fact, according to the flowchart, 14,819 studies were identified. 39 were duplicates and, therefore, removed. Authors identified more than 14,000 potentially relevant articles during the electronic search, but at the end of the process only 16 articles were included. A more refined search strategy should have been used for a more accurate result. Why did the authors include only 13 studies in the meta-analysis? Why were 3 studies excluded? Line 201 and 209: “dentoalveolar abscess (DAA) and related periapical lesions.” What lesions? Line 232: S3 table should be moved to the methods section. Lines 240 to 245: wouldn't this paragraph be a DISCUSSION of the results? Why did the authors include acute abscess AND abscess? Why were the studies that evaluated Chronic DAA. not included in the meta-analysis? Couldn't it be a bias? Line 274, 277, 280: The author refers to figure 2A, 2B and 2C, but this figure does not specify which is ABC. Meta regression: Is there any limitation by using this analysis? Because there are few studies that evaluated unculturable bacteria in “periapical abscess” and “acute DAA” (type of lesion). Data would not show the real effect of the lesion type on prevalence of unculturable bacteria. Besides that, could the sample collection procedure be a specific moderator? Line 338 to 347: Wouldn't this paragraph be a METHODOLOGY? Line 348 to 373: For the diversity of unculturable bacteria in periapical abscess, the study number 8 “is an outlying study but not influential, so it was not removed.” But, for abundance estimation, the “tests reveal that the 3rd study [33] is an influential study on the effect of summary proportion”. Why this study was not removed? Discussion: Since the number of bacteria is normally greater and more virulent in symptomatic and purulent infections than in chronic and asymptomatic infections, could the inclusion of studies that do not specify what type of ADA in the meta-analysis characterize a bias in the results? Line 417: This was the diversity found for all abscesses. Lines 418 and 419: Authors could rewrite this sentence for better understanding. Line 424 AND 439: Are authors suggesting any explanation for the country's interference? Is the collection method important? More information regarding the importance of the knowledge on the prevalence of unculturable bacteria in dentoalveolar abscess and related periapical lesions should be included in this section. The authors could improve the discussion. What is the importance of knowing the frequency, abundance and diversity of these bacteria? What are the suggestions for new studies? Do the authors suggest an explanation for the significant publication bias for the frequency estimate of unculturable bacteria and for the outlier? Regarding chronic ADA, can different results be found? What is the contribution of this study? There could be a last paragraph summarizing the findings. Conclusions: Authors state that the prevalence of unculturable bacteria is ABUNDANT and at the conclusion of the abstract they state that it is MODERATE. Please, review these statements. The conclusion could be more objective and in accordance with the aim of the study. Reviewer #2: This manuscript discusses the role unculturable bacteria in the dentoalveolar abscess and how it effects on the periapical lesions in depth through systematic review and Meta-analysis as study design. The meta analysis for this study is very good. The number of included studies in this study is expected due to new idea and the number of studies related to the topic is very small and future studies are required in this field. I think this paper eligible to publish in peer review journal like this journal. Reviewer #3: The authors should revise the nomenclature of periapical lesions and acute apical abscess and change them in entire manuscript according to the guidelines of the AAE (diagnosis). Dentoalveolar abscess may involve lesions of not only endodontic origin Two studies (Jacinto et al. 2007 and Vengerfeldt et al. 2014) included in the review did not have their data clarified regarding the diagnosis. Have the authors contacted the corresponding authors to clarify the diagnosis gap? It seems that in the Jacinto et al (2007) the paper point samples were collected from root canals of symptomatic teeth (i.e. with acute apical abscess). Great number of the studies included in this review were from Brazil. The authors highlighted a high discrepancy in the results found in these studies. Is there any hypothesis for this diversity of uncultivable bacteria found in studies carried out in the Brazilian population? Please clarify the origin of the sample collected. For instance, Jacinto el al collected samples from the root canals of symptomatic teeth. On the other hand, Siqueira and Rocas (2007) and many other authors collected samples from the purulent collection. Another point that needs to clarify is the presence of abscess in primary or in adult dentition. For example, Zhang et al studied the presence of abscess in primary teeth (children). It would be interesting to explain the differences between uncultivable, unculturable and uncultivated bacteria. Reviewer #4: Review Comments to the Author: Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) (Limit 200 to 20000 Characters) Could you please see my attached review, I have added all my comments to the Author in an attachment. Reviewer #5: Abstract - Revise for uniformity, and stick to the Journal's Guidelines. "( P -value = 0.05)" must read "(p = 0.050)". Revise thoroughly. - With your conclusions, please stick exclusively to your aims. See: "To assess the prevalence of uncultivable bacteria in dentoalveolar abscess (DAA) and related periapical lesions." Now, you conclude that "unculturable bacteria in such lesions (...) are likely to play, a yet unknown, critical role in the pathogenesis and progression of the disease". This is something different, and you surely will agree. - "More search remains to be done on the communal behaviour, virulence, and pathogenicity in this ecosystem." This is a common phrase only, but not an answer to your research question. - Please stick to the word maximum allowed here, to provide complete information. Intro - With respect to the research question, this section is considered much too long. Please shorten significantly, and elaborate both aims and objectives more clearly. - What about your null hypothesis? Meths - Why did you restrict your inclusion criteria to English? Results - This has been meticulously elaborated. Disc - Please do not use authors' names with your text (these will be acknowledged with your reference list). Instead, do focus on your main thoughts. - This section is considered easily intelligible. Concl - Please see comments given above. With your Conclusions, please stick exclusively to your revised aims. Do not simply repeat your results here. Instead, provide a reasonable and generalizable extension of your outcome. - See, for example, "Despite the remarkable diversity of uncultivable bacteria in these lesions, their role in the pathogenesis is yet to be determined. A positive correlation was shown between the abundance and frequency of individual uncultivable bacteria. Peptostreptococcus sp. oral clone CK035 showed the highest abundance and frequency. Hybridization techniques appear to be more reliable in detecting the abundance and frequency of individual unculturable bacteria in periapical lesions." All these aspects would seem right, and, thus, these thoughts might be copied & pasted to your Disc section. However, these are not considered conclusions deducible from your study. Refs - Full of minor and major shortcomings. Please revise for uniform formatting. - Again, stick to the Journal's guidelines, and consult some recently published Plos One papers. - doi numbers are missing. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Faisal Turki Alghamdi Reviewer #3: No Reviewer #4: No Reviewer #5: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Prevalence of unculturable bacteria in the periapical abscess: A systematic review and meta-analysis PONE-D-20-39104R1 Dear Dr. Hamoudi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, congratulations and compliments, and stay healthy Andrej M Kielbassa, Prof. Dr. med. dent. Dr. h. c. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed Reviewer #5: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly Reviewer #5: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #5: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #5: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #5: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear Authors, Thank you for accepting the recommendations. Now, I am satisfied with the changes made and I recommend publishing the manuscript in its current format. Reviewer #2: The authors followed the reviewer comments as well as. The paper looks good after the revision. I think it deserve published in good peer-review journal. Reviewer #5: This revised and re-submitted draft has been thoroughly improved. Still, some minor typos would seem perfectible. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Reviewer #5: No |
| Formally Accepted |
|
PONE-D-20-39104R1 Prevalence of unculturable bacteria in the periapical abscess: A systematic review and meta-analysis Dear Dr. Hamoudi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Dr. med. dent. Dr. h. c. Andrej M Kielbassa Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .